Beta‐blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

A preclinical study demonstrated anti‐proliferative and apoptotic effect of propranolol on multiple myeloma (MM) cell. Clinical studies suggested that beta‐blocker (BB) might impact the prognosis of breast, prostate, colorectal, ovarian, lung, and skin cancer. This retrospective study evaluated the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwa, Yi L., Shi, Qian, Kumar, Shaji K., Lacy, Martha Q., Gertz, Morie A., Kapoor, Prashant, Buadi, Francis K., Leung, Nelson, Dingli, David, Go, Ronald S., Hayman, Suzanne R., Gonsalves, Wilson I., Russell, Stephen, Lust, John A., Lin, Yi, Rajkumar, S. Vincent, Dispenzieri, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217079/
https://www.ncbi.nlm.nih.gov/pubmed/27733010
http://dx.doi.org/10.1002/ajh.24582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217079/
https://www.ncbi.nlm.nih.gov/pubmed/27733010
http://dx.doi.org/10.1002/ajh.24582

Ejemplares similares